APA (7th ed.) Citation

Butler, J., Filippatos, G., Siddiqi, T. J., Brückmann, M., Bohm, M., Chopra, V. K., . . . Anker, S. D. (2022). Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: The EMPEROR-preserved trial. Circulation, 145(3), . https://doi.org/10.1161/CIRCULATIONAHA.121.057812

Chicago Style (17th ed.) Citation

Butler, Javed, et al. "Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-preserved Trial." Circulation 145, no. 3 (2022). https://doi.org/10.1161/CIRCULATIONAHA.121.057812.

MLA (9th ed.) Citation

Butler, Javed, et al. "Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-preserved Trial." Circulation, vol. 145, no. 3, 2022, https://doi.org/10.1161/CIRCULATIONAHA.121.057812.